THC Financial Statements From 2010 to 2025
| THCT Stock | USD 0.0003 0.00 0.00% |
Check THC Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among THC Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . THC financial statements analysis is a perfect complement when working with THC Therapeutics Valuation or Volatility modules.
THC |
THC Therapeutics Company Return On Asset Analysis
THC Therapeutics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current THC Therapeutics Return On Asset | -5.57 |
Most of THC Therapeutics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, THC Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, THC Therapeutics has a Return On Asset of -5.5725. This is 36.31% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
THC Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining THC Therapeutics's current stock value. Our valuation model uses many indicators to compare THC Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across THC Therapeutics competition to find correlations between indicators driving THC Therapeutics's intrinsic value. More Info.THC Therapeutics is rated fourth in return on asset category among its peers. It is rated third in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the THC Therapeutics' earnings, one of the primary drivers of an investment's value.About THC Therapeutics Financial Statements
THC Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although THC Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in THC Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on THC Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
It is involved in the development of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested cannabis, other herbs, flowers, and tea leaves. THC Therapeutics, Inc. was incorporated in 2007 and is based in Las Vegas, Nevada. Thc Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for THC Pink Sheet Analysis
When running THC Therapeutics' price analysis, check to measure THC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Therapeutics is operating at the current time. Most of THC Therapeutics' value examination focuses on studying past and present price action to predict the probability of THC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Therapeutics' price. Additionally, you may evaluate how the addition of THC Therapeutics to your portfolios can decrease your overall portfolio volatility.